Table 3 Comparison of treatment outcomes of ultra-high-risk GTN patients for liver or brain metastases (n=18)
Ultra-high-risk GTN patients: FIGO score >12, as well as patients with liver, brain, or extensive metastases.
* Chi-squared test, P<0.05 indicates statistical significant